Glioblastoma and Other Malignant Gliomas
Memorial Sloan Kettering Cancer Center
Abstract
Glioblastomas and malignant gliomas are the most common primary malignant brain tumors, with an annual incidence of 5.26 per 100,000 population or 17,000 new diagnoses per year. These tumors are typically associated with a dismal prognosis and poor quality of life.
To review the clinical management of malignant gliomas, including genetic and environmental risk factors such as cell phones, diagnostic pitfalls, symptom management, specific antitumor therapy, and common complications. EVIDENCE REVIEW: Search of PubMed references from January 2000 to May 2013 using the terms glioblastoma, glioma, malignant glioma, anaplastic astrocytoma, anaplastic oligodendroglioma, anaplastic oligoastrocytoma, and brain neoplasm. Articles were also identified through searches of the authors' own files. Evidence was graded using the American Heart Association classification system.
Citation impact
- FWCI
- 61.38
- Percentile
- 100%
- References
- 63
Authors
1Topics & keywords
- Medicine
- Temozolomide
- Anaplastic astrocytoma
- Glioma
- Bevacizumab
- Radiation therapy
- Oncology
- Internal medicine
- No poverty